Director · Organogenesis Holdings Inc. · Class A Common Stock
Side
A
Value
—
Shares
48.8K
Price
—
Executed
Feb 18, 2026
Disclosed
Feb 20, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Feb 18 executedFeb 20, 2026 disclosed
ORGO · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+9 / 25
No reported dollar value · 29.3% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Driscoll Michael Joseph filed this Form 4 reporting a grant or award of ORGO on Feb 18, 2026. It became public on Feb 20, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Driscoll Michael Josephcik:0001912097
Issuer
Organogenesis Holdings Inc.cik:0001661181
Revision history · 0
No field has changed since this record was first ingested.
